Vidcast:  https://youtu.be/Ce4du1KeMQg

 

Those with lingering CoVid symptoms can safely receive an mRNA or an adenoviral vector vaccine, and vaccination is associated with overall improvement in symptoms.  British researchers report these findings after  studying 66 CoVid long-haulers two-thirds of whom were vaccinated with either the Pfizer or the Oxford-AstraZeneca vaccines.

 

Vaccination was well-tolerated with no significant degradation in quality-of-life.  Two thirds noted transient systemic reactions included fever, muscle aches, and headache.  Those vaccinated were 41% less likely to experience escalation of their CoVid-related symptoms but were 1.5 times more likely to enjoy greater symptom resolution.  Both vaccines seemed to produce similar results.

 

CoVid long-haulers should get vaccinated.

 

https://www.medrxiv.org/content/10.1101/2021.03.11.21253225v1.full.pdf+html

 

#Longhaulers #CoVid #vaccine #pfizer #astrazeneca